• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic warns on connectivity issue with Guardian Connect app

July 10, 2018 By Sarah Faulkner

MedtronicMedtronic (NYSE:MDT) this month issued a letter to physicians warning them of a potential connectivity issue with the Guardian Connect mobile app.

The medtech giant warned that people using the Guardian Connect system to keep track of their blood sugar levels should update to the latest version of the mobile app as soon as possible.

Medtronic explained that patients have reported the app closing without warning, preventing them from receiving potential alerts associated with hypo- or hyperglycemic events. The company noted that it hasn’t yet received any reports of injury.

Guardian Connect users can remedy the situation by updating to the latest version of the app (v3.2.2), which can be found in the App store.

“As described in the patient’s App User Guide, Medtronic cannot guarantee that the iPhone will always allow for the Guardian Connect app to run in the background. If the iPhone automatically closes the Guardian Connect app, patients may receive a ‘Lost Communication’ alert. To ensure patients continue receiving sensor glucose data and alerts, we recommended that they periodically check that the Guardian Connect app is still running, being especially mindful when running several applications at once,” the company said.

Medtronic won FDA approval for its Guardian Connect CGM system in March this year. The company touts its system as the first connected standalone CGM designed to help people with diabetes avoid high and low glucose events.

Using Medtronic’s Guardian Sensor 3, the system alerts its users of potential high or low glucose events up to 60 minutes in advance. In one study, the Guardian Connect accurately alerted patients to 98.5% of all hypoglycemic events, according to Medtronic.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, mHealth (Mobile Health), Patient Monitoring, Wall Street Beat Tagged With: Medtronic

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS